Skip to main content
SpringerLink
Log in

Cost-effective OCD treatment: CBT, SSRI or both?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fineberg NA, et al. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. International Clinical Psychopharmacology : 15 Aug 2018. Available from: URL: http://doi.org/10.1097/YIC.0000000000000237

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost-effective OCD treatment: CBT, SSRI or both?. PharmacoEcon Outcomes News 811, 6 (2018). https://doi.org/10.1007/s40274-018-5235-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5235-1

Search

Navigation